News & Insights

In anticipation of International Women's Day tomorrow, we salute "Practical Innovation." our esteemed client and a leading entity in the realm of Israeli innovation, predominantly managed and operated by women. Tal Leizer, CEO and founder, established the company in 2010 following her tenure as CMO and PDM at notable food companies, including Shemen Industries Ltd. and Soglowek. The inception of Practical Innovation aimed to inject groundbreaking innovation into the product launch process—a challenge many businesses find daunting—thereby fueling a significant growth engine tailored to each business and its unique capabilities.

In the four decades that have passed since the fatal AIDS disease erupted in 1981, considerable efforts were and continue to be invested into developing treatments. This has been largely successful. Today AIDS is no longer a life-threatening disease. The first breakthrough occurred when scientists succeeded in identifying the…

One might wonder what Thomas Edison and the Lumière brothers would have thought about it... What is considered to be audiovisual heritage in today's digital age?

In a few months a monumental change in the European patent landscape will take place with the coming into force of the Unified Patent Court (UPC) of the European Union (EU). This change will permit patentees to have a single Unified Patent (UP) across most of EU territory and, hence, covering one of the three largest economic regions of the world.

November 14 was designated by the United Nations as World Diabetes Day. The prevalence of diabetes has increased dramatically over recent decades and reached a global epidemic level, with major health and health economic consequences worldwide.

The World Intellectual Property Organization (WIPO) published a report earlier this week on global intellectual property (IP) activity in 2020. There are some very interesting findings in this report, that provide an insight on global economic activity and trends, as summarized below.

The Israeli Parliament (the Knesset) has voted, in a first reading, in favor of a proposed amendment to the Israeli Patents Law (1967) that aims to increase the global competitive advantage of Israeli generic pharmaceutical companies.

Antibody-based therapeutics play a central role in medicine and patent protection is critical to reaping the financial benefits from such successful therapeutic agents. Recent occurrences suggest that the barriers to securing broad patent protection in the US have increased. Innovative companies should develop and practice proper patent strategies ensuring that they receive the proper exclusionary patent protection that antibody-related innovations deserve.